Naveed Zafar Janjua
Scientist, MBBS, M.SC., DRPH
At BCCDC, Dr. Janjua provides leadership on surveillance, research and policy advice, and programming related to hepatitis B and C in British Columbia.
Research Interests
- Hepatitis B and C
- Syndemics of substance use, mental illness and blood-borne and sexually transmitted infections (STBBIs)
- Intervention effectiveness
- Health disparities
His research interests include hepatitis B and C epidemiology, syndemics of substance use, mental illness and blood-borne and sexually transmitted infections, intervention effectiveness, disparities in treatment access and disease outcomes, and strategies to enhance access to care.
Most of his current work is based on the BC Hepatitis Testers Cohort. His global health research includes unsafe medical injections and transmission of bloodborne pathogens, socio-economic disparities in health, and scale-up of hepatitis testing and treatment in South Asia developing countries. He has been involved in initiatives to design and scale-up testing, linkage with care and treatment for HCV in various settings. He is also a member of various national networks including the Canadian Hepatitis C Network (CanHepC) and the CIHR Canadian HIV Trials Network (CTN).
Additional Affiliations
- Interim Director, Public Health Analytics, BC Centre for Disease Control
- Senior Scientist, Hepatitis, BC Centre for Disease Control
- Clinical Associate Professor, School of Population and Public Health, University of British Columbia
Media Coverage
- Up to one in 20 new diabetes cases could be linked to Covid, study suggests (The Guardian, April 2023)
- Risk of heart inflammation higher with Moderna vaccine: study (CTV News, November 2022)
- COVID-19: B.C. survey tracks human interactions to measure impact on transmission rate (Vancouver Sun, February 2021)
- All pregnant women should be tested for hepatitis C: B.C. experts (Vancouver Sun, June 2019)
